AI Analysis AI Analysis of PRFX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PRFX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

PainReform Ltd. stock price took a fall of -5.63% on Friday
(Updated on Jun 26, 2026)

Sell candidate since Jun 18, 2026 Loss -8.48%

The PainReform Ltd. stock price fell by -5.63% on the last day (Friday, 26th Jun 2026) from $1.60 to $1.51. During the last trading day the stock fluctuated 7.33% from a day low at $1.50 to a day high of $1.61. The price has fallen in 7 of the last 10 days but is still up by 2.03% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -14 million shares and in total, 454 thousand shares were bought and sold for approximately $684.88 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -26.45% during the next 3 months and, with a 90% probability hold a price between $0.732 and $1.99 at the end of this 3-month period.

PRFX Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 24, 2026, and so far it has risen 7.09%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The PainReform Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.58 and $1.68. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for PainReform Ltd. stock

PainReform Ltd. finds support from accumulated volume at $1.46 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.110 between high and low, or 7.33%. For the last week the stock has had daily average volatility of 19.85%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PRFX) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect PainReform Ltd. to open at $1.54, and during the day (based on 14 day Average True Range), to move between $1.28 and $1.74, which gives a possible trading interval of +/-$0.453 (+/-35.34%) up or down from last closing price. If PainReform Ltd. takes out the full calculated possible swing range there will be an estimated 35.34% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.46 (3.31%) than the resistance at $1.60 (5.96%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is PainReform Ltd. stock A Buy?

PainReform Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.483 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $1.54 ( 1.99%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PRFX Performance

Trading levels for PRFX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.65 9.27%
R2 1.61 6.49%
R1 1.58 4.77%
Price 1.51
S1 1.50 -0.796%
S2 1.47 -2.52%
S3 1.43 -5.30%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.85 22.52%
R2 1.84 21.85%
R1 1.60 5.96%
Price 1.51
S1 1.46 -3.31%
S2 1.45 -3.97%
S3 1.42 -5.96%

FAQ

What is the symbol for PainReform Ltd. Stock and on which exchange is it traded?
The symbol for PainReform Ltd. is PRFX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell PainReform Ltd. Stock?
PainReform Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy PainReform Ltd. Stock?
PainReform Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy PainReform Ltd. Stock.

What's the current price of PainReform Ltd. Stock?
As of the end of day on the Jun 26, 2026, the price of an PainReform Ltd. (PRFX) share was $1.51.

What is the 52-week high and low for PainReform Ltd. Stock?
The 52-week high for PainReform Ltd. Stock is $89.75 and the 52-week low is $1.28.

What is the market capitalization of PainReform Ltd. Stock?
As of the Jun 26, 2026, the market capitalization of PainReform Ltd. is 121.603K.
Click to get the best stock tips daily for free!
ABOUT PAINREFORM LTD.
PainReform
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the tre...
GOLDEN STAR
Ticker Change Signal Date
JLL
$299.78
5.10% Jun 24
NMRK
$15.02
1.66% Jun 24
X
XMAX
$8.34
5.40% Jun 24
NESR
$25.07
12.64% Jun 23
TTEK
$28.04
4.35% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE